Tormo M A, Martínez I M, Romero de Tejada A, Gil-Exojo I, Campillo J E
Department of Physiology, Faculty of Medicine, University of Extremadura, Badajoz, Spain.
Exp Clin Endocrinol Diabetes. 2002 May;110(3):119-23. doi: 10.1055/s-2002-29088.
Summary. Many studies have shown that experimental type 1 diabetes causes morphological, functional, and metabolic alterations in the small intestine. The more frequent form of the disease, type 2 diabetes, however, has been less studied. Here the influence of diabetes on the functionality of the small intestine was studied in an experimental diabetes model, with a certain degree of residual insulin secretion, specifically in the n0-STZ model. - The diabetic rats in this model were found to have glycaemia levels higher than in the controls (8.82 +/- 0.27 and 6.18 +/- 0.18 mmol/L; p < 0.01), while their plasma insulin levels were lower than in the control rats (2.65 +/- 0.32 and 3.60 +/- 0.25 ng/ml; p < 0.05). Although there were no significant variations in body weight between the two groups, both the weight and the length of the intestine were significantly greater (p < 0.05) in the diabetic rats than in the controls. The sucrase and maltase activities were greater (p < 0.01) in the proximal intestine of the diabetic rats (94 +/- 8 and 234 +/- 12 mU/mg protein, respectively) than in the control rats (50 +/- 2 and 149 +/- 20 mU/mg protein, respectively). The 6-phosphofructo-1-kinase activity (mU/mg proteins) was less (p < 0.05) in the proximal and distal intestine of the diabetic rats (160 +/- 40 and 80 +/- 20, respectively) than in the controls (280 +/- 30 and 230 +/- 30, respectively). No significant differences were observed in the lactate dehydrogenase or active and total pyruvate dehydrogenase measured in the distal and proximal intestine of control and diabetic rats. In conclusion, our results show that experimental diabetes (n0-STZ model) similar to human type 2 diabetes produces certain morphological and enzymatic alterations which affect the digestion and absorption of carbohydrates and the intestinal metabolism of glucose. These alterations may contribute to producing the post-prandial hyperglycaemia which characterizes diabetes.
摘要。许多研究表明,实验性1型糖尿病会导致小肠出现形态、功能和代谢改变。然而,更为常见的2型糖尿病,其相关研究较少。在此,我们在一种具有一定程度残余胰岛素分泌的实验性糖尿病模型,即n0-STZ模型中,研究了糖尿病对小肠功能的影响。该模型中的糖尿病大鼠血糖水平高于对照组(分别为8.82±0.27和6.18±0.18 mmol/L;p<0.01),而其血浆胰岛素水平低于对照大鼠(分别为2.65±0.32和3.60±0.25 ng/ml;p<0.05)。尽管两组之间体重无显著差异,但糖尿病大鼠的小肠重量和长度均显著大于对照组(p<0.05)。糖尿病大鼠近端小肠中的蔗糖酶和麦芽糖酶活性(分别为94±8和234±12 mU/mg蛋白)高于对照大鼠(分别为50±2和149±20 mU/mg蛋白)(p<0.01)。糖尿病大鼠近端和远端小肠中的6-磷酸果糖-1-激酶活性(mU/mg蛋白)低于对照组(近端分别为160±40和280±30,远端分别为80±20和230±30)(p<0.05)。在对照大鼠和糖尿病大鼠的近端和远端小肠中测量的乳酸脱氢酶、活性丙酮酸脱氢酶和总丙酮酸脱氢酶均未观察到显著差异。总之,我们的结果表明,类似于人类2型糖尿病的实验性糖尿病(n0-STZ模型)会产生某些形态和酶学改变,这些改变会影响碳水化合物的消化和吸收以及肠道葡萄糖代谢。这些改变可能有助于产生糖尿病所特有的餐后高血糖。